Check-Cap Ltd. Ordinary Share (MBAI)
Stock · NASDAQ · Health Care
$2.75as of 10/16/2026
Price chart
Active signals
MBAI Signal Track Record
How signals performed across all stocks →What MBAI's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 40 | -10.0% | 35% | September 10, 2026 |
| Bollinger Band Breakdown | 22 | -1.0% | 45% | September 23, 2026 |
| Bollinger Band Breakout | 19 | -10.1% | 26% | August 5, 2026 |
| 200-Day Moving Average TouchActive now | 3 | -8.3% | 33% | April 24, 2026 |
| Any 20-session window (baseline) | -5.6% | 36% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About MBAI
MBody AI Ltd. designs and develops embodied artificial intelligence software for autonomous workforce and operational automation. Its flagship platform, the MBody AI Orchestrator is an AI-driven enterprise software platform that monitors, coordinates and manages robotic and sensor fleets to optimize physical work operations. Its platform provides perception AI for computer vision and environmental understanding, cogn…
- Sector
- Health Care
- Industry
- Medical Electronics
- Website
- check-cap.com/
Fundamentals
- 1-day range
- $2.58$3.06
- Market cap
- $10.04M
- P/E (trailing)
- 4.99
- P/E (forward)
- Infinity
- EPS (trailing)
- $1.56
- Dividend yield
- —
- Beta
- 0.76
- Avg. volume
- 20.9K
Forecasts
1 analyst ratings
Check-Cap Ltd. Ordinary Share Competitors
Chosen by industry and closest market cap.
- MBAICheck-Cap Ltd. Ordinary Share$2.75▼ 11.29%Market cap $10.04MP/E 4.99$3$27.44
- NNOXNANO-X IMAGING LTD Ordinary Shares$0.453▼ 7.74%Market cap $70.98MP/E —$0.5$4.71
- BFLYButterfly Network Inc. Class A Common Stock$7.25▼ 7.64%Market cap $2.21BP/E —$1.9$10.21
- PHGKoninklijke Philips N.V. NY Registry Shares$25.74▲ 0.98%Market cap $25.88BP/E 19.62$20.9$27.7
- GEHCGE HealthCare Technologies Inc. Common Stock$69.57▼ 1.11%Market cap $31.76BP/E 16.01$58.75$89.77
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MBAI Check-Cap Ltd. Ordinary Share | $10.04M | 4.99 | $2.75 | ▼ 11.29% | $3$27.44 |
| NNOX NANO-X IMAGING LTD Ordinary Shares | $70.98M | — | $0.453 | ▼ 7.74% | $0.5$4.71 |
| BFLY Butterfly Network Inc. Class A Common Stock | $2.21B | — | $7.25 | ▼ 7.64% | $1.9$10.21 |
| PHG Koninklijke Philips N.V. NY Registry Shares | $25.88B | 19.62 | $25.74 | ▲ 0.98% | $20.9$27.7 |
| GEHC GE HealthCare Technologies Inc. Common Stock | $31.76B | 16.01 | $69.57 | ▼ 1.11% | $58.75$89.77 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- EXCLUSIVE: Robotics Has A Dell-HP Problem—and This AI Company Wants To Solve ItBenzinga · 9/25/2026
- EXCLUSIVE: The Robot Arms Race Has A New Battlefield — CasinosBenzinga · 9/25/2026
- MBody AI Completes Name Change Following Merger and $10 Million OfferingYahoo · 9/16/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
MBAI gets Outperform rating and $10 target from Northland Capital
Northland Capital Markets initiated coverage on MBody AI with an Outperform rating and a $10 price target. The company also presented its AI robot workforce platform at the Lytham Fall 2026 Conference. These developments occur while the stock trades well below its 52-week high, reflecting a significant gap between the new analyst target and current market prices.
MBAI gets Outperform rating and $10 target from Northland Capital. Northland Capital Markets initiated coverage on MBody AI with an Outperform rating and a $10 price target. The company also presented its AI robot workforce platform at the Lytham Fall 2026 Conference. These developments occur while the stock trades well below its 52-week high, reflecting a significant gap between the new analyst target and current market prices.